ES2190730B1 - Composicion farmaceutica para tratar la congestion nasal via sistemica. - Google Patents

Composicion farmaceutica para tratar la congestion nasal via sistemica.

Info

Publication number
ES2190730B1
ES2190730B1 ES200101346A ES200101346A ES2190730B1 ES 2190730 B1 ES2190730 B1 ES 2190730B1 ES 200101346 A ES200101346 A ES 200101346A ES 200101346 A ES200101346 A ES 200101346A ES 2190730 B1 ES2190730 B1 ES 2190730B1
Authority
ES
Spain
Prior art keywords
nasal congestion
pharmaceutical composition
treat nasal
via systems
congestion via
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200101346A
Other languages
English (en)
Other versions
ES2190730A1 (es
Inventor
Ana Maria Jimenez
Antonia Gomez
Mercedes Chacon
Nuria Sanz
Laura Berges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Priority to ES200101346A priority Critical patent/ES2190730B1/es
Publication of ES2190730A1 publication Critical patent/ES2190730A1/es
Application granted granted Critical
Publication of ES2190730B1 publication Critical patent/ES2190730B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composición para tratar la congestión nasal, que consiste en incorporar pseudoefedrina sulfato en una forma farmacéutica masticable mediante la cual, durante su ingesta se logra una descongestión nasal por vía sistémica, incorporando goma base, xylitol, manitol, glicerina, jarabe de maltitol, acesulfame K, aspartamo, sulfato de pseudoefedrina, aromas y sorbitol.
ES200101346A 2001-06-11 2001-06-11 Composicion farmaceutica para tratar la congestion nasal via sistemica. Expired - Fee Related ES2190730B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200101346A ES2190730B1 (es) 2001-06-11 2001-06-11 Composicion farmaceutica para tratar la congestion nasal via sistemica.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101346A ES2190730B1 (es) 2001-06-11 2001-06-11 Composicion farmaceutica para tratar la congestion nasal via sistemica.

Publications (2)

Publication Number Publication Date
ES2190730A1 ES2190730A1 (es) 2003-08-01
ES2190730B1 true ES2190730B1 (es) 2004-12-01

Family

ID=27675887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101346A Expired - Fee Related ES2190730B1 (es) 2001-06-11 2001-06-11 Composicion farmaceutica para tratar la congestion nasal via sistemica.

Country Status (1)

Country Link
ES (1) ES2190730B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017103348A1 (fr) * 2015-12-17 2017-06-22 Urgo Recherche Innovation Et Developpement Composition liquide pour son utilisation comme solution nasale

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800083A (en) * 1986-10-20 1989-01-24 R. P. Scherer Corporation Sustained release method and product
US5560921A (en) * 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
JP3733140B2 (ja) * 1993-06-04 2006-01-11 ワーナー−ランバート・コンパニー 多重作用性風邪／鼻づまり製剤
WO2000023046A1 (en) * 1998-10-16 2000-04-27 Bush Boake Allen Inc. Chewable or dissolvable pharmaceutical compositions suitable for oral administration
CA2366845A1 (en) * 1999-03-22 2000-09-28 Atp Avant-Garde Technologies & Product Marketing & Licensing S.A. Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained

Also Published As

Publication number Publication date
ES2190730A1 (es) 2003-08-01

Similar Documents

Publication Publication Date Title
ATE264102T1 (de) Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption
WO2004069198A3 (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
ATE431738T1 (de) Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
BR9909266A (pt) Formulações efervescentes
AR019935A1 (es) Preparacion solida de desintegracion rapida, uso de una hidroxipropil celulosa poco sustituida en dicha preparacion y metodo para mejorar la capacidad dedesintegracion rapida de la misma
UY28285A1 (es) Péliculas consumibles por vía oral que se disuelven rápidamente, que contienen un edulcorante
JP2004505028A5 (es)
BR0016402A (pt) Método para aumentar a permeabilidade da pele ou do tecido mucoso a agentes farmaceuticamente ou cosmeticamente ativos administrados por via tópica ou transdérmica
AR060931A1 (es) Producto farmaceutico recubierto para la administracion intraoral de nicotina y su uso y elaboracion
JP2009503097A5 (es)
AR027033A1 (es) Composicion estable para dosis oral de liberacion extendida
ES2192265T3 (es) Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente.
NO20030915L (no) Fremgangsmåte for bedövelse
RU2007127999A (ru) Орально распадающееся фармацевтические композиции с сенсорными сигнальными агентами
SG152257A1 (en) Topical preparation containing ambroxol
ES2314304T3 (es) Composiciones farmaceuticas topicas que contienen principios activos naturales adecuados para la prevencion y el tratamiento de procesos inflamatorios de las mucosas.
ATE541562T1 (de) Ibuprofen-suspension
ATA2332000A (de) Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
AR069572A1 (es) Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
BR0308927A (pt) Comprimido mastigável de sabor agradável
UY27505A1 (es) Tableta masticable que contiene lisina
DE60205905D1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
ES2190730B1 (es) Composicion farmaceutica para tratar la congestion nasal via sistemica.
BR0308038A (pt) Ambroxol para o tratamento de estados doloridos na cavidade bucal e faringe
BR0315482A (pt) Composições farmacêuticas e formas de dosagem para liberações bucal e sublingual da tizanidina e métodos de administração da tizanidina de forma sublingual ou bucal

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030801

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2190730B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180928